3Forouzanfar MH, Foreman K J, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: A sys- tematic analysis [ J]. Lancet, 2011,378 (9801) : 1461 - 1484.
5Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embol- ism of the european society of cardiology (esc) [J]. Eur Heart J, 2008,29 ( 18 ) : 2276 - 2315.
6Buchholz TA. Radiotherapy and survival in breast cancer [ J ]. Lancet, 2011,378 (9804) : 1680 - 1682.
7Kunkler I. Adjuvant chest wall radiotherapy for breast cancer: black, white and shades of grey [ J]. Eur J Surg Oncol, 2010,36 (4) :331 -334.
8Fowler JF. 21 years of biologically effective dose [J]. Brit J Radi- ol, 2010,83 (991) :554 - 568.
9Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of arandomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [ J]. New Engl J Med, 2002,347 (16) : 1233 - 1241.
10Freedman GM, White JR, Arthur DW, et al. Accelerated frac- tionation with a concurrent boost for early stage breast cancer [ J]. Radiother Oncol, 2013,106 ( 1 ) : 15 - 20.
5Meena M.Radiation therapy in the locoregional treatment of triple-negative breast cancer[J].Lancet Oncol,2015,16(3):113-122.
6Boyle P.Triple-negative breast cancer:epidemiological considerations and recommendations[J].Ann Oncol,2012,23(6):7-12.
7Sioshansi S,Ehdaivand S,Cramer C,et al.Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy[J].Cancer,2012,118(16):3893-3898.
8Part A,Adamo B,Cheang MC,et al.Molecular characterization of basal-like and non-basal-like triple-negative berast cancer[J].Oncologist,2013,18(2):123-133.
9Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest,2011,121(7):2750-2767.
10Lehmann BD,Pietenpol JA.Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes[J].J Pathol,2014,232(2):142-150.
